Genzhou Liu Selected Research

Microbial Collagenase (Clostridiopeptidase A)

5/2022	Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials.
1/2021	Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled Trials.
1/2020	Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie's Disease.
1/2019	Collagenase Clostridium Histolyticum for the Treatment of Edematous Fibrosclerotic Panniculopathy (Cellulite): A Randomized Trial.
11/2017	Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
9/2017	Factors Associated With Erectile Dysfunction and the Peyronie's Disease Questionnaire in Patients With Peyronie Disease.
8/2017	Safety Profile of Collagenase Clostridium Histolyticum Stratified by Degree of Penile Curvature in Patients With Peyronie Disease.
1/2015	Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Genzhou Liu Research Topics

Disease

5	Congenital Abnormalities (Deformity) 01/2020 - 01/2015
4	Cellulite 05/2022 - 01/2019
4	Penile Induration (Peyronie's Disease) 01/2020 - 01/2015
1	Bronchopulmonary Dysplasia 01/2009
1	Pneumonia (Pneumonitis) 01/2009
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2007

Drug/Important Bio-Agent (IBA)

8	Microbial Collagenase (Clostridiopeptidase A)FDA Link 05/2022 - 01/2015
2	CollagenIBA 05/2022 - 01/2019
2	Peptides (Polypeptides)IBA 01/2009 - 06/2007
2	lucinactantIBA 01/2009 - 06/2007
2	Surface-Active Agents (Surfactants)IBA 01/2009 - 06/2007
1	propylene diquat (PDQ(+))IBA 11/2017
1	Pharmaceutical PreparationsIBA 01/2015
1	Oxidants (Oxidizing Agents)IBA 01/2009
1	Oxygen (Dioxygen)IBA 01/2009
1	tyloxapol drug combination hexadecanol dipalmitoylphosphatidylcholine (Exosurf Neonatal)FDA Link 06/2007

Therapy/Procedure

3	Therapeutics 11/2017 - 06/2007
2	Injections 01/2019 - 08/2017
1	Aftercare (After-Treatment) 12/2020
1	Intralesional Injections 01/2015